Prothena Corp Public Ltd Co (PRTA) stock
PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3020% below fair value
$8.35+0.09 (+1.09%)
Close on Nov 18, 2026Market cap $428.66MP/E –Yield –
Prothena Corp Public gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Prothena Corp Public
Prothena Corp Public has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?